Compare Cronos Group Inc (CRON) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Nvidia Corp — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.03B), while Nvidia Corp trades at $210.96 (market cap $4.93T). The key difference: Nvidia Corp is far larger — about 4786.4× Cronos Group Inc's market cap, and Nvidia Corp pays a 0.49% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | NVDA | |
|---|---|---|
Market Cap | $1.03B | $4.93T |
Sector | Health | Technology |
52-Week High | $3.27 | $235.75 |
52-Week Low | $1.95 | $165.17 |
Enterprise Value | $211.19M | $4.86T |
Dividend Yield | — | 0.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
NVIDIA (NVDA) trades at $203.53, down 3.52% on the day, with a bullish technical outlook supported by moving averages and key support at $201. The company reported strong revenue growth to $130.50B in 2025, with net income surging to $72.88B and a robust net margin of 55.84%. Recent earnings beats and a consensus analyst price target of $325.86 highlight strong fundamental momentum amid AI-driven demand.
Outlook remains positive with AI infrastructure expansion driving growth, though risks include increased competition and market volatility. Wall Street sentiment is bullish with 75% buy ratings, but investors should monitor execution risks and macroeconomic headwinds that could impact valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
